Corbevax gets DCGI nod for use as booster jab

Hyderabad-based Biological E Limited’s Covid-19 vaccine Corbevax has emerged as the first vaccine to bag approval from the Drug Controller General of India for use as a heterologous booster dose, for those aged 18 years and above, after 6 months of administration of the second dose of either Covaxin or Covishield.

Click here for more...
from #Bangladesh #News aka Bangladesh News Now!!!